IFC catalyzes breakthrough in Africa’s vaccine manufacturing: Biovac launches cholera vaccine trials
Biovac, a client of the International Finance Corporation (IFC), has initiated clinical trials for South Africa’s first domestically developed oral cholera vaccine—a milestone achievement for African health security. This innovation…